Immunotherapy and Paraneoplastic Neurological Syndromes

NCT02343211 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Paraneoplastic Neurological Syndromes

Interventions

DRUG: Immunoglobulin

Sponsor

Assistance Publique - Hôpitaux de Paris